The term "sundowning" describes a clinical phenomenon characterized by late afternoon exacerbation of behavioural symptoms in dementia. Beyond this clinical definition, the debate around this concept is not properly solved, because many authors define it in different ways, mentioning various hypothetical etiological explanations. It represents a concrete problem, which is difficult to manage for physicians and caregivers, and is probably linked to various biological, psychological and social aspects. As recently reported, the sundowning phenomenon is a predictor of faster cognitive decline in Alzheimer's disease, and as such can represent a possible marker of frailty in this illness. This article presents an overview of the biological understanding and possible pharmacological and non-pharmacological treatment of this condition.

Ferrazzoli, D., Sica, F., Sancesario, G. (2013). Sundowning syndrome: a possible marker of frailty in Alzheimer's disease?. CNS & NEUROLOGICAL DISORDERS. DRUG TARGETS, 12(4), 525-528.

Sundowning syndrome: a possible marker of frailty in Alzheimer's disease?

SANCESARIO, GIUSEPPE
2013-06-01

Abstract

The term "sundowning" describes a clinical phenomenon characterized by late afternoon exacerbation of behavioural symptoms in dementia. Beyond this clinical definition, the debate around this concept is not properly solved, because many authors define it in different ways, mentioning various hypothetical etiological explanations. It represents a concrete problem, which is difficult to manage for physicians and caregivers, and is probably linked to various biological, psychological and social aspects. As recently reported, the sundowning phenomenon is a predictor of faster cognitive decline in Alzheimer's disease, and as such can represent a possible marker of frailty in this illness. This article presents an overview of the biological understanding and possible pharmacological and non-pharmacological treatment of this condition.
giu-2013
Pubblicato
Rilevanza internazionale
Articolo
Sì, ma tipo non specificato
Settore MED/26 - NEUROLOGIA
English
Con Impact Factor ISI
Cholinesterase Inhibitors; Aged, 80 and over; Humans; Frail Elderly; Alzheimer Disease; Sleep Disorders; Aged; Psychomotor Agitation; Chronobiology Disorders; Phototherapy
Ferrazzoli, D., Sica, F., Sancesario, G. (2013). Sundowning syndrome: a possible marker of frailty in Alzheimer's disease?. CNS & NEUROLOGICAL DISORDERS. DRUG TARGETS, 12(4), 525-528.
Ferrazzoli, D; Sica, F; Sancesario, G
Articolo su rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2108/101144
Citazioni
  • ???jsp.display-item.citation.pmc??? 3
  • Scopus 11
  • ???jsp.display-item.citation.isi??? 8
social impact